Incyte (INCY) reports Q3: everything you need to know ahead of earnings

Barchart·10/27/2026 22:28:26

Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) will be reporting results this Thursday before market open. Here’s what to look for.

Incyte beat analysts’ revenue expectations last quarter, reporting revenues of $1.67 billion, up 37.7% year on year. It was a satisfactory quarter for the company, with a beat of analysts’ EPS estimates but full-year revenue guidance missing analysts’ expectations significantly.

Is Incyte a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, the market is expecting Incyte’s revenue to grow 7.4% year on year, slowing from the 20% increase it recorded in the same quarter last year.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. Incyte has a history of exceeding Wall Street’s expectations.

With Incyte being the first among its peers to report earnings this season, we don’t have anywhere else to look to get a hint at how this quarter will unfold for biotechnology stocks. However, there has been positive investor sentiment in the segment, with share prices up 3.6% on average over the last month. Incyte is down 6.6% during the same time .

ALSO WORTH WATCHING: Nvidia’s Quiet Partner. Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all.

Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. Claim The Stock Ticker Here for FREE.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.